MultiCell Technologies Inc (MCET)

[bontooth]

. . Email from Barb

i asked:

1) are we still partners with Amarin on this MCT-125 study?
reading the last 10-Q it appears Amarin is conducting only to phase 2a

2) will Amarin conduct the phase 2b as well?
3) is there a chance that MCT-125 could get "fast tracked" through phase 2b and
into phase 3?

Barb's reply:

Thank you for your interest in MultiCell's pipeline of therapeutics. Due to SEC prohibitions on giving out forward-looking information or revealing anything to an individual that is not already in the public domain and due to the forward-looking nature of your questions, my response has to be:

1) Still partners with Amarin on MCT-125. No comment about Amarin sponsored clinical trials.

2) No comment in response to both questions.

Best regards,
Barbara Corbett, Investor Relations,